Create
Log in
Enquire now
Azafaros
Developer of therapeutics for rare lysosomal storage disorders.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
CEO
Stefano Portolano
COO
Silvia Ragno
Country
Netherlands
Email Address
info@azafaros.com
Founded Date
2018
Headquarters
Naarden
Industry
Pharmaceutical industry
Biotechnology
Manufacturing
Health technology
Investors
BioMedPartners
0
Jeito Capital
The Pictet Group
Forbion Capital Partners
Seroba Life Science
BioGeneration Ventures
Schroders Capital
Latest Funding Round Date
May 13, 2025
Latest Funding Round Amount (USD)
147,000,000
Latest Funding Type
Series B
LinkedIn URL
@company/37801478
Location
Switzerland
Netherlands
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
174,500,000
Official Website
azafaros.com
Find more companies like Azafaros
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Pricing
Enterprise
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE